LONDON, June 10, 2014 /PRNewswire/ --
The trading session on Monday, June 09, 2014 ended on a higher note as the Dow Jones Industrial Average finished at 16,943.10, up 0.11% and the NASDAQ Composite closed at 4,336.24, up 0.34%. The S&P 500 finished the day 0.09% higher at 1,951.27. During the trading session, six out of ten sectors finished on a positive note. The S&P 500 Health Care Sector Index ended the day 0.48% lower at 691.34, while the index has advanced 3.44% in the previous one month. Investor-Edge has initiated coverage on the following equities: Agilent Technologies Inc. (NYSE: A), Thermo Fisher Scientific Inc. (NYSE: TMO), PerkinElmer Inc. (NYSE: PKI) and Quintiles Transnational Holdings Inc. (NYSE: Q). Free technical research on A, TMO, PKI and Q can be downloaded upon signing up at:
http://www.investor-edge.com/3629-register
On Monday, shares in Agilent Technologies Inc. recorded a trading volume of 1.19 million shares, which was below its three months average volume of 2.12 million shares. The stock finished the day at $59.28, which was 0.46% higher its previous day's closing of $59.01, and registered an intraday range of $58.70 and $59.58. Over the previous three trading sessions and in the last one month, Agilent Technologies Inc.'s stock has gained 3.19% and 7.02%, respectively. Moreover, the company's stock has advanced 3.65% on YTD basis. The company's shares are trading above their 50-day and 200-day moving averages. The stock's 50-day moving average of $55.35 is above its 200-day moving average of $54.42. Further, Agilent Technologies Inc.'s stock traded at a PE ratio of 24.86 and has a Relative Strength Index (RSI) of 71.71. Sign up today to read free research on A at:
http://www.investor-edge.com/3629-A-10Jun2014.pdf
Shares in Thermo Fisher Scientific Inc. fluctuated between $119.28 and $120.04 before ending Monday's session 0.19% lower at $119.58. The company's stock reported a trading volume of 1.24 million shares, below its three months average volume of 2.05 million shares. The company's stock traded at a PE ratio of 34.69. Over the previous three trading sessions and in the last one month, shares in Thermo Fisher Scientific Inc. have advanced 1.53% and 2.56%, respectively. Additionally, the company's shares are up 7.39% on YTD basis. Thermo Fisher Scientific Inc.'s stock is trading above its 50-day and 200-day moving averages of $117.29 and $108.41, respectively. Moreover, the company's shares and have an RSI of 60.16. Sign up today to read free research on TMO at:
http://www.investor-edge.com/3629-TMO-10Jun2014.pdf
PerkinElmer Inc.'s stock fell by 1.07% on Monday, closing the session at $47.01, also hitting a new 52-week high of $47.64. A total of 0.94 million shares were traded, above its three months average volume of 0.84 million shares. The stock moved between $46.96 and $47.64 during the session. Shares of the company traded at a PE ratio of 29.28. Shares in PerkinElmer Inc. have gained 1.64% in the previous three trading sessions, 7.77% in the last one month and 14.02% from the beginning of 2014. PerkinElmer Inc.'s shares are trading above their 50-day and 200-day moving averages of $44.31 and $41.26, respectively. Further, the company's stock has an RSI of 76.28. Sign up today to read free research on PKI at:
http://www.investor-edge.com/3629-PKI-10Jun2014.pdf
On Monday, shares in Quintiles Transnational Holdings Inc. edged 0.02% lower, closing the day at $52.98. The stock recorded a trading volume of 0.45 million shares, which was below its three months average volume of 0.95 million shares. The company's stock oscillated between $52.88 and $53.22 during the session. Shares in Quintiles Transnational Holdings Inc. have advanced 0.67% in the previous three trading sessions and 11.44% in the last one month. Moreover, the company's stock has surged 14.33% on YTD basis. Quintiles Transnational Holdings Inc.'s shares are trading above their 50-day and 200-day moving averages of $49.86 and $47.26, respectively. Furthermore, the company's stock traded at a PE ratio of 23.73 and has an RSI of 72.96. Sign up today to read free research on Q at:
http://www.investor-edge.com/3629-Q-10Jun2014.pdf
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
http://www.investor-edge.com
SOURCE Investor-Edge
